[Non-virilizing hormonal therapy in women with secondary disorders of sexual responsiveness].
26 women with secondary disturbance of sexual responsiveness were treated mainly with dehydroepiandrosterone preparations. The sexual tonus was tested before and after treatment by a sexual score system previously described. Urinary 17-ketosteroid and plasma testosterone fractions were controlled in 17 patients; these values were, in general, below the normal range before treatment. Treatment was considered to be successful in 17 patients, while in the remaining 9, who mainly belonged to the group of younger patients, no success was achieved. However, the results point out that therapeutic success with hormones of low biological activity can be expected only after numerous months of treatment. The pattern obtained on determination of hormonal parameters usually corresponded to the results of treatment.
D000328:Adult; D002996:Clomiphene / Q000627:therapeutic use; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use; D003687:Dehydroepiandrosterone / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000652:urine; D004338:Drug Combinations / Q000627:therapeutic use; D004958:Estradiol / Q000031:analogs & derivatives / Q000627:therapeutic use; D005043:Etiocholanolone / Q000652:urine; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D007989:Libido / Q000187:drug effects; D008297:Male; D008655:Mesterolone / Q000627:therapeutic use; D009644:Norgestrel / Q000627:therapeutic use; D009948:Orgasm / Q000187:drug effects; D012735:Sexual Dysfunction, Physiological / Q000628:therapy*; D013739:Testosterone / Q000097:blood
D003277:Contraceptives, Oral, Combined; D004338:Drug Combinations; D008655:Mesterolone; D002996:Clomiphene; C033624:dehydroepiandrosterone enanthate; D009644:Norgestrel; D013739:Testosterone; D003687:Dehydroepiandrosterone; D004958:Estradiol; D016912:Levonorgestrel; C033625:Gynodian; D005043:Etiocholanolone
Nichtvirilisierende Hormontherapie bei sekundär gestörter weiblicher Sexualbereitschaft.